Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

47
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
47
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

46.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.1K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

811
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
811
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

614
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
614

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

BlOFP1 is associated with reduced secondary cell wall formation and interacts with BlKNOX9 and BlBLH9 in Betula luminifera.

Plant science : an international journal of experimental plant biology·2026
Same author

Community-level COVID-19 vaccination promotion capacity and its association with vaccination dose per capita in China: an entropy-weighted TOPSIS and multilevel analysis.

BMC public health·2026
Same author

Post-pandemic impact on the epidemiology of invasive pneumococcal disease: consensus statement from the Latin American Society of Pediatric Infectious Diseases (SLIPE).

Expert review of vaccines·2026
Same author

Neutralizing antibodies as A therapy for hepatitis E virus: Advances, challenges and opportunities.

Antiviral research·2026
Same author

Invasive Pneumococcal Disease in Argentine Children After Widespread PCV13 Use: Burden, Potential PCV20 Coverage and Mortality Risk Factors Across Three Years of Surveillance.

The Pediatric infectious disease journal·2026
Same author

Prenatal Diagnosis of Conotruncal Anomalies Before 16 Weeks: Longitudinal Evolution, Genetic Findings and Early Prognostic Markers.

Prenatal diagnosis·2026

相关实验视频

Updated: Jul 15, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K

甲型肝炎病毒感染感染.

Pierre Van Damme1, Rosa M Pintó2, Zongdi Feng3

  • 1Centre for the Evaluation of Vaccination, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. pierre.vandamme@uantwerpen.be.

Nature reviews. Disease primers
|September 28, 2023
PubMed
概括
此摘要是机器生成的。

甲型肝炎是一种可预防的肝炎感染. 疫苗接种和改善卫生是减少全球病例和预防肝衰竭等严重后果的关键.

更多相关视频

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.4K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.2K

相关实验视频

Last Updated: Jul 15, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.4K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.2K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 传染性疾病 传染性疾病
  • 疫苗学 疫苗学 疫苗学

背景情况:

  • 甲型肝炎病毒 (HAV) 每年导致超过1.5亿例感染,导致急性肝炎.
  • 虽然HAV通常会自行解决,但在很少的病例中,它可能会导致长期的疾病,复发或急性肝衰竭.
  • 疾病的严重程度受宿主因素的影响,包括免疫状况,年龄,怀孕和先前存在的肝病.

研究的目的:

  • 总结甲型肝炎的流行病学,临床表现和预防策略.
  • 突出疫苗接种和公共卫生措施在控制HAV传播中的作用.

主要方法:

  • 审查关于甲型肝炎流行病学和临床结果的现有文献.
  • 世界卫生组织 (WHO) 疫苗接种建议的分析.
  • 检查公共卫生干预措施对HAV发病率的影响.

主要成果:

  • 甲型肝炎感染是可以通过疫苗预防的,通过自然感染或接种疫苗可以获得终身免疫力.
  • 世卫组织建议在流行性较低的地区进行基于风险的疫苗接种,在流行性中等的地区进行普遍的儿童疫苗接种.
  • 超过25个实施疫苗接种计划的国家已经减少了HAV发病率.

结论:

  • 疫苗接种和改善卫生/卫生条件对于减少甲型肝炎的传播和疾病负担至关重要.
  • 迅速识别和干预疫情爆发对于有效控制至关重要.
  • 甲型肝炎疫苗接种计划在全球降低感染率方面取得了成功.